NICE Ltd.: Form 20-F for the period ended Dec 31, 2014
Filed with the SEC on Apr 2, 2015 and accepted by EDGAR at Apr 2, 2015, 16:01 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2014-01-01 to 2014-12-31 | $1.01bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months2014-01-01 to 2014-12-31 | $375.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2014-01-01 to 2014-12-31 | $636.1m | us-gaap:GrossProfit |
| Research and development | 12 months2014-01-01 to 2014-12-31 | $148.6m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2014-01-01 to 2014-12-31 | $111.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2014-01-01 to 2014-12-31 | $73.0k | us-gaap:InterestExpense |
| Income tax | 12 months2014-01-01 to 2014-12-31 | $11.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2014-01-01 to 2014-12-31 | $103.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2014-01-01 to 2014-12-31 | $1.69 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2014-01-01 to 2014-12-31 | $1.74 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2014-01-01 to 2014-12-31 | 60,892 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2014-01-01 to 2014-12-31 | $182.3m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 12 months2014-01-01 to 2014-12-31 | $16.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2014-01-01 to 2014-12-31 | $38.1m | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months2014-01-01 to 2014-12-31 | $94.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2014-12-31 | $187.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-12-31 | $506.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-12-31 | $1.64bn | us-gaap:Assets |
| Current liabilities | At period end2014-12-31 | $378.2m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2014-12-31 | $1.21bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2014-12-31 | 59,252,342 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001178913-15-001185. Last ingested by Listed: Nov 5, 2026, 14:06 ET. Listed shows no prices and gives no investment advice.